How should I switch a patient from sertraline to lamotrigine?

Switching from Sertraline to Lamotrigine

You cannot directly "switch" from sertraline to lamotrigine in the traditional sense because these medications serve fundamentally different therapeutic purposes and require distinct management strategies. Sertraline is an SSRI antidepressant, while lamotrigine is a mood stabilizer/anticonvulsant, and they are not interchangeable treatments.

Understanding the Clinical Context

The approach depends entirely on why you're making this medication change:

If Treating Depression/Anxiety (Most Likely Scenario)

Lamotrigine is being added as augmentation, not as a replacement for sertraline. This is the most common clinical scenario:

• Do not discontinue sertraline when starting lamotrigine for treatment-resistant depression
• Lamotrigine augmentation of antidepressants (including sertraline) has demonstrated efficacy in treatment-resistant unipolar depression 1
• Patients with more severe illness and longer duration respond better to lamotrigine augmentation 1

Lamotrigine Titration Schedule:

• Start at 25 mg/day for 2 weeks
• Increase to 50 mg/day for weeks 3-4
• Then 100 mg/day for weeks 5-6
• Target maintenance dose: 100-200 mg/day
• Slow titration is mandatory to minimize risk of serious rash

Critical Drug Interaction Warning

Sertraline can significantly increase lamotrigine blood levels, potentially causing toxicity 2, 3:

• Case reports document lamotrigine levels doubling with sertraline co-administration, even at low sertraline doses (25 mg/day) 2
• Toxicity can occur even with "therapeutic" lamotrigine levels when combined with sertraline 3
• Monitor closely for signs of lamotrigine toxicity: mental status changes, delirium, ataxia, diplopia, tremor

Management Strategy:

• Consider using lower lamotrigine doses than typical when combined with sertraline
• Monitor for toxicity symptoms, especially during dose adjustments
• Clinical correlation is more important than blood levels alone 3
• If lamotrigine toxicity develops, reduce lamotrigine dose (not sertraline) first

If Actually Discontinuing Sertraline

If you genuinely need to stop sertraline (due to intolerance, side effects, or switching to lamotrigine monotherapy for bipolar disorder):

Sertraline Discontinuation Protocol 4:

1. Taper gradually - sertraline is associated with discontinuation syndrome 5
2. Reduce dose by 25-50% every 1-2 weeks (faster than fluoxetine due to shorter half-life)
3. Monitor for discontinuation symptoms: dizziness, fatigue, paresthesias, anxiety, irritability, insomnia, nausea, headache 5

Timing Considerations:

• No specific washout period required between sertraline and lamotrigine (unlike MAOIs which require 14 days) 4
• Can start lamotrigine while tapering sertraline if clinically indicated
• However, be aware of the interaction risk noted above

If Switching to Lamotrigine for Bipolar Disorder

If the patient was misdiagnosed with unipolar depression and actually has bipolar disorder:

• Screen for bipolar disorder before discontinuing antidepressants 4
• Lamotrigine is FDA-approved for bipolar maintenance, not acute mania
• Cross-taper approach: Start lamotrigine at low dose while gradually reducing sertraline over 4-6 weeks
• Ensure mood stability before completing sertraline discontinuation
• Consider adding an antimanic agent if needed during transition

Common Pitfalls to Avoid

1. Never abruptly stop sertraline - risk of severe discontinuation syndrome 5, 4
2. Never rapid-titrate lamotrigine - risk of Stevens-Johnson syndrome
3. Never assume "therapeutic" lamotrigine levels are safe when combined with sertraline 3
4. Never use lamotrigine as monotherapy for acute depression - it's an augmentation strategy, not first-line antidepressant 1

Monitoring Requirements

• Weekly assessment during first month of lamotrigine titration
• Monitor for rash (stop immediately if develops)
• Assess for lamotrigine toxicity symptoms (confusion, ataxia, diplopia)
• Track mood symptoms and suicidality during sertraline taper 4
• Consider lamotrigine levels if toxicity suspected, but rely on clinical presentation 3